Brief: SkinBioTherapeutics Says Martin Hunt Assumes Role Of Executive Chairman Temporarily

Skinbiotherapeutics

16/02/2026 07:23

Feb 16 (Reuters) - SkinBioTherapeutics PLC SBTX.L:

SKINBIOTHERAPEUTICS  - UPDATE ON BOARD INVESTIGATION

SKINBIOTHERAPEUTICS PLC: NEW INFORMATION HAS LED BOARD TO SEEK REVERSAL OF ALL ACCRUED ROYALTY INCOME FROM AUDITED FY25 REVENUES

SKINBIOTHERAPEUTICS PLC: ONGOING INVESTIGATION INTO CONDUCT OF FORMER CEO

SKINBIOTHERAPEUTICS PLC - PROCESS UNDERWAY TO APPOINT INTERIM AND PERMANENT CEO

SKINBIOTHERAPEUTICS PLC: EXPECTS THAT FY25 ACCRUED ROYALTY INCOME, WHICH AMOUNTED TO £0.77M, WILL BE REMOVED FROM FY25 ACCOUNTS

SKINBIOTHERAPEUTICS PLC: ANTICIPATES THAT RESULTS FOR YEAR ENDED 30 JUNE 2026 WILL BE SIGNIFICANTLY BELOW CURRENT MARKET EXPECTATIONS

SKINBIOTHERAPEUTICS PLC - MARTIN HUNT ASSUMES ROLE OF EXECUTIVE CHAIRMAN TEMPORARILY

Source text: ID:nRSP0617Ta

Further company coverage: SBTX.L

 (((( Reuters.Briefs@thomsonreuters.com ;));))